Le dipyridamole possède des propriétés antiagrégantes plaquettaires mises en évidence in vitro. Il inhibe in vitro et in vivo le captage de l'adénosine dans les plaquettes, les cellules endothéliales et les hématies. Adenosine official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. i. La Base Claude Bernard (BCB) est une base de données sur les médicaments et les produits de santé qui a pour but d'aider les professionnels de santé dans leur exercice quotidien de prescription, délivrance et dispensation et de fournir une information exhaustive au grand public. LA REVUE PRESCRIRE - GUIDE INTERACTIONS MÉDICAMENTEUSES 2016 •PAGE 1 Interactions médicamenteuses - Comprendre et décider - 2016 Outil numérique Easy-to-read patient leaflet for Adenosine. Includes indications, proper use, special instructions, precautions, and possible side effects. Dipyridamole increases the exposure to adenosine. Manufacturer advises avoid or adjust dose. Medical uses. Dipyridamole is used to dilate blood vessels in people with peripheral arterial disease and coronary artery disease; Dipyridamole has been shown to lower pulmonary hypertension without significant drop of systemic blood pressure AGGRENOX ® (aspirin/dipyridamole) for Oral Use. DESCRIPTION. AGGRENOX is a combination antiplatelet agent intended for oral administration. Each hard gelatin capsule contains 200 mg dipyridamole in an extended-release form and 25 mg aspirin, as an immediate-release sugar-coated tablet. Methylxanthines (e.g., caffeine, found in coffee, or theophylline in tea, or theobromine, as found in chocolate) competitively antagonize adenosine's effects; an increased dose of adenosine may be required. DRUG INTERACTIONS. Intravenous Adenocard (adenosine injection) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.